DanDrit Biotech USA Inc Share Price OTC Bulletin Board
Equities
US2360781015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
04-24 | Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics | MT |
04-18 | Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 34.41M 2.72B |
---|---|---|---|---|---|
Net income 2022 | -113M -8.93B | Net income 2023 | -39M -3.08B | EV / Sales 2022 | - |
Net cash position 2022 | 1.99M 157M | Net Debt 2023 | 3.9M 309M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.89
x | P/E ratio 2023 |
-0.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.85% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 22/01/18 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 20/08/23 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 31/12/19 |
Avram Miller
BRD | Director/Board Member | - | 10/10/23 |
James Sapirstein
BRD | Director/Board Member | 63 | 05/03/18 |
1st Jan change | Capi. | |
---|---|---|
+8.29% | 114B | |
+10.21% | 104B | |
+0.58% | 22.28B | |
-11.90% | 22.41B | |
-4.73% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |